{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:35:06Z","timestamp":1793723706580,"version":"4.6.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.berh.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T09:42:13Z","timestamp":1550137333000},"page":"541-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity"],"prefix":"10.1016","volume":"32","author":[{"given":"Anida","family":"Grosicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Manasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Kucharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw J.","family":"Kotyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2019.01.005_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2019.01.005_bib2","first-page":"1","article-title":"Therapy of systemic sclerosis","volume":"56","author":"Valentini","year":"2004","journal-title":"Reumatismo"},{"key":"10.1016\/j.berh.2019.01.005_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.02.00081102","article-title":"Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis","volume":"19","author":"Greene","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2019.01.005_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","article-title":"Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent","volume":"162","author":"Takahashi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2019.01.005_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib8","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.005_bib9","series-title":"Scleroderma-modern aspects of pathogenesis, diagnosis and therapy","author":"Distler","year":"2009"},{"key":"10.1016\/j.berh.2019.01.005_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/rheumatology\/ken309","article-title":"Skin involvement in systemic sclerosis","volume":"47","author":"Czirjak","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.005_bib12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/ard.2006.066530","article-title":"The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis","volume":"66","author":"Czirj\u00e1k","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fisher","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2019.01.005_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-2007-985611","article-title":"Computed tomographic imaging in connective tissue disease","volume":"28","author":"Devaraj","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.berh.2019.01.005_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/ken313","article-title":"Pulmonary function tests","volume":"47","author":"Behr","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.005_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.berh.2013.03.001","article-title":"How to perform and interpret capillaroscopy","volume":"27","author":"Cutolo","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib17","first-page":"42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","article-title":"Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"44","author":"Asano","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.005_bib20","first-page":"1112","article-title":"Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis","volume":"31","author":"Yanaba","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib21","first-page":"27","article-title":"Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement","volume":"28","author":"Bonella","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.berh.2019.01.005_bib22","first-page":"414","article-title":"Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato\/polymyositis","volume":"26","author":"Kum\u00e1novics","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3899\/jrheum.120997","article-title":"Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?","volume":"40","author":"Elhaj","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.005_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.162.1.9903014","article-title":"Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis","volume":"162","author":"Takahashi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.berh.2019.01.005_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1346-8138.2001.tb00013.x","article-title":"Surfactant protein D (SP-D) and systemic scleroderma (SSc)","volume":"28","author":"Maeda","year":"2001","journal-title":"J\u00a0Dermatol"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:17:27Z","timestamp":1761499047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219300063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1521694219300063"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.01.005","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}